Multimodal cardiovascular magnetic resonance quantifies regional variation in vascular structure and function in patients with coronary artery disease: Relationships with coronary disease severity

Journal of Cardiovascular Magnetic Resonance

Volumn 13, Issue 1, 2011, Pages

  Kylintireas, Ilias ^a   Shirodaria, Cheerag ^a   Lee, Justin M S ^a   Cunningon, Colin ^a   Lindsay, Alistair ^a   Francis, Jane ^a   Robson, Matthew D ^a   Neubauer, Stefan ^a   Channon, Keith M ^a   Choudhury, Robin P ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Atherosclerosis; coronary artery disease; magnetic resonance imaging

Indexed keywords

ADULT; ARTERY COMPLIANCE; ARTICLE; ASCENDING AORTA; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL FUNCTION; BLOOD VESSEL WALL; BRACHIAL ARTERY; CARDIOVASCULAR MAGNETIC RESONANCE; CAROTID ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; DESCENDING AORTA; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; AGED; ANALYSIS OF VARIANCE; ANGIOCARDIOGRAPHY; AORTA; AORTA DISEASE; ATHEROSCLEROSIS; CAROTID ARTERY; CAROTID ARTERY DISEASE; CHI SQUARE DISTRIBUTION; COMPLIANCE (PHYSICAL); CORONARY ARTERY DISEASE; HOSPITALIZATION; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; UNITED KINGDOM; VASODILATATION;

AGED; ANALYSIS OF VARIANCE; AORTA; AORTIC DISEASES; ATHEROSCLEROSIS; BRACHIAL ARTERY; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CHI-SQUARE DISTRIBUTION; COMPLIANCE; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; ENGLAND; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; VASODILATION;

EID: 84860549803     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-13-61     Document Type: Article

References (49)

1. Atherosclerosis imaging as a benchmark in the development of novel cardiovasular drugs. Duivenvoorden R, Nederveen AJ, de Groot E, et al. Curr Opin Lipidol 2007 18 613 21 10.1097/MOL.0b013e3282f19608 17993805 (Pubitemid 350098565)
2. Form to function: current and future roles for atherosclerosis imaging in drug development. Lindsay AC, Choudhury RP, Nat Rev Drug Discov 2008 7 517 29 10.1038/nrd2588 18483481 (Pubitemid 351767119)
3. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. Brown BG, Zhao XQ, Chait A, et al. N Engl J Med 2001 345 1583 92 10.1056/NEJMoa011090 11757504 (Pubitemid 33126837)
4. Lipid Lowering by Simvastatin Induces Regression of Human Atherosclerotic Lesions: Two Years' Follow-Up by High-Resolution Noninvasive Magnetic Resonance Imaging. Corti R, Fuster V, Fayad ZA, et al. Circulation 2002 106 2884 7 10.1161/01.CIR.0000041255.88750.F0 12460866 (Pubitemid 35424736)
5. Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis: A Randomized Controlled Trial. Nissen SE, Tuzcu EM, Schoenhagen P, et al. JAMA 2004 291 1071 80 10.1001/jama.291.9. 1071 14996776 (Pubitemid 38541684)
6. Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial. Bots ML, Visseren FL, Evans GW, et al. Lancet 2007 370 153 60 10.1016/S0140-6736(07)61088-5 17630038 (Pubitemid 47042895)
7. Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia. Kastelein JJ, van Leuven SI, Burgess L, et al. N Engl J Med 2007 356 1620 30 10.1056/NEJMoa071359 17387131 (Pubitemid 46631671)
8. Effect of torcetrapib on the progression of coronary atherosclerosis. Nissen SE, Tardif JC, Nicholls SJ, et al. N Engl J Med 2007 356 1304 16 10.1056/NEJMoa070635 17387129 (Pubitemid 46513296)
9. Early changes in arterial structure and function following statin initiation: quantification by magnetic resonance imaging. Lee JM, Wiesmann F, Shirodaria C, et al. Atherosclerosis 2008 197 951 8 10.1016/j.atherosclerosis. 2007.09.001 17977546 (Pubitemid 351417906)
10. Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial. Underhill HR, Yuan C, Zhao XQ, et al. Am Heart J 2008 155 584 e1 8
11. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. Tahara N, Kai H, Ishibashi M, et al. J Am Coll Cardiol 2006 48 1825 31 10.1016/j.jacc.2006.03.069 17084257 (Pubitemid 44648621)
12. Application of intravascular ultrasound in anti-atherosclerotic drug development. Nicholls SJ, Sipahi I, Schoenhagen P, et al. Nat Rev Drug Discov 2006 5 485 92 10.1038/nrd2040 16699493 (Pubitemid 44136960)
13. Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis: The ASTEROID Trial. Nissen SE, Nicholls SJ, Sipahi I, et al. JAMA 2006 295.13.jpc60002
14. Intravascular Ultrasound: Novel Pathophysiological Insights and Current Clinical Applications. Nissen SE, Yock P, Circulation 2001 103 604 16 11157729 (Pubitemid 32116248)
15. Carotid intima-media thickness measurements in intervention studies: design options, progression rates, and sample size considerations: a point of view. Bots ML, Evans GW, Riley WA, et al. Stroke 2003 34 2985 94 10.1161/01.STR.0000102044.27905.B5 14615619 (Pubitemid 37517782)
16. Increased High-Density Lipoprotein Cholesterol Predicts the Pioglitazone-Mediated Reduction of Carotid Intima-Media Thickness Progression in Patients With Type 2 Diabetes Mellitus. Davidson M, Meyer PM, Haffner S, et al. Circulation 2008 117 2123 30 10.1161/CIRCULATIONAHA.107.746610 18413496 (Pubitemid 351572171)
17. Comparison of the effects of losartan and atenolol on common carotid artery intima-media thickness in patients with hypertension: results of a 2-year, double-blind, randomized, controlled study. Ludwig M, Stapff M, Ribeiro A, et al. Clin Ther 2002 24 1175 93 10.1016/S0149-2918(02)80028-5 12182261 (Pubitemid 34833239)
18. One-year reduction and longitudinal analysis of carotid intima-media thickness associated with colestipol/niacin therapy. Mack WJ, Selzer RH, Hodis HN, et al. Stroke 1993 24 1779 83 10.1161/01.STR.24.12.1779 8248954 (Pubitemid 23352702)
19. ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial. Meuwese MC, de Groot E, Duivenvoorden R, et al. JAMA 2009 301 1131 9 10.1001/jama.301.11. 1131 19293413
20. Effect of gemfibrozil on early carotid atherosclerosis in diabetic patients with hyperlipidaemia. Migdalis IN, Gerolimou B, Kozanidou G, et al. Int Angiol 1997 16 258 61 9543224 (Pubitemid 28120578)
21. Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus. Sidhu JS, Kaposzta Z, Markus HS, et al. Arterioscler Thromb Vasc Biol 2004 24 930 4 10.1161/01.ATV.0000124890.40436.77 15001452 (Pubitemid 38620874)
22. Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins. Taylor AJ, Sullenberger LE, Lee HJ, et al. Circulation 2004 110 3512 7 10.1161/01.CIR.0000148955.19792.8D 15537681 (Pubitemid 39612564)
23. Effects of Aggressive Versus Conventional Lipid-Lowering Therapy by Simvastatin on Human Atherosclerotic Lesions: A Prospective, Randomized, Double-Blind Trial With High-Resolution Magnetic Resonance Imaging. Corti R, Fuster V, Fayad ZA, et al. Journal of the American College of Cardiology 2005 46 106 10.1016/j.jacc.2005.03.054 15992643 (Pubitemid 40905137)
24. Early changes in arterial structure and function following statin initiation: Quantification by magnetic resonance imaging. Lee JM, Wiesmann F, Shirodaria C, et al. Atherosclerosis 2007
25. Sample size calculation for clinical trials using magnetic resonance imaging for the quantitative assessment of carotid atherosclerosis. Saam T, Kerwin WS, Chu B, et al. J Cardiovasc Magn Reson 2005 7 799 808 10.1080/10976640500287703 16353440 (Pubitemid 41770058)
26. MRI of atherosclerosis in clinical trials. Yuan C, NMR in Biomedicine 2006 19 636 54 10.1002/nbm.1065 16986119 (Pubitemid 44515609)
27. In vivo quantification of carotid artery wall dimensions: 3.0-Tesla MRI versus B-mode ultrasound imaging. Duivenvoorden R, de Groot E, Elsen BM, et al. Circ Cardiovasc Imaging 2009 2 235 42 10.1161/CIRCIMAGING.108.788059 19808598
28. Testing the hypothesis of atherosclerotic plaque lipid depletion during lipid therapy by magnetic resonance imaging: study design of Carotid Plaque Composition Study. Zhao XQ, Phan BA, Chu B, et al. Am Heart J 2007 154 239 46 10.1016/j.ahj.2007.04.035 17643572 (Pubitemid 47069140)
29. Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI: a case-control study. Zhao XQ, Yuan C, Hatsukami TS, et al. Arterioscler Thromb Vasc Biol 2001 21 1623 9 10.1161/hq1001.098463 11597936 (Pubitemid 34215582)
30. MRI and Characterization of Atherosclerotic Plaque: Emerging Applications and Molecular Imaging. Choudhury RP, Fuster V, Badimon JJ, et al. Arterioscler Thromb Vasc Biol 2002 22 1065 74 10.1161/01.ATV.0000019735.54479.2F 12117718 (Pubitemid 34764854)
31. Global impairment of brachial, carotid, and aortic vascular function in young smokers: direct quantification by high-resolution magnetic resonance imaging. Wiesmann F, Petersen SE, Leeson PM, et al. J Am Coll Cardiol 2004 44 2056 64 10.1016/j.jacc.2004.08.033 15542292 (Pubitemid 39473292)
32. Multi-modal magnetic resonance imaging quantifies atherosclerosis and vascular dysfunction in patients with type 2 diabetes mellitus. Lee JM, Shirodaria C, Jackson CE, et al. Diab Vasc Dis Res 2007 4 44 8 10.3132/dvdr.2007.005 17469043 (Pubitemid 46649073)
33. Molecular, cellular and functional imaging of atherothrombosis. Choudhury RP, Fuster V, Fayad ZA, Nat Rev Drug Discov 2004 3 913 25 10.1038/nrd1548 15520814 (Pubitemid 39529929)
34. Differences in carotid arterial morphology and composition between individuals with and without obstructive coronary artery disease: a cardiovascular magnetic resonance study. Underhill HR, Yuan C, Terry JG, et al. J Cardiovasc Magn Reson 2008 10 31 10.1186/1532-429X-10-31 18549502
35. Cardiovascular magnetic resonance parameters of atherosclerotic plaque burden improve discrimination of prior major adverse cardiovascular events. Mani V, Muntner P, Gidding SS, et al. J Cardiovasc Magn Reson 2009 11 10 10.1186/1532-429X-11-10 19393089
36. A more meaningful scoring system for determining the severity of coronary heart disease. Gensini GG, Am J Cardiol 1983 51 606 10.1016/S0002-9149(83) 80105-2 6823874 (Pubitemid 13187192)
37. A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors. Sullivan DR, Marwick TH, Freedman SB, Am Heart J 1990 119 1262 7 10.1016/S0002-8703(05)80173- 5 1972310 (Pubitemid 20215609)
38. In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Yuan C, Mitsumori LM, Ferguson MS, et al. Circulation 2001 104 2051 6 10.1161/hc4201.097839 11673345 (Pubitemid 33027045)
39. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Virmani R, Kolodgie FD, Burke AP, et al. Arterioscler Thromb Vasc Biol 2000 20 1262 75 10.1161/01.ATV.20.5. 1262 10807742 (Pubitemid 30262927)
40. Carotid intima-media thickness by B-mode ultrasound as surrogate of coronary atherosclerosis: correlation with quantitative coronary angiography and coronary intravascular ultrasound findings. Amato M, Montorsi P, Ravani A, et al. Eur Heart J 2007 28 2094 101 10.1093/eurheartj/ehm244 17597051 (Pubitemid 47517440)
41. High Dose Modified-release Nicotinic Acid Reduces Carotid Atherosclerosis: a Randomized, Placebo-controlled Magnetic Resonance Study. Lee JM, Robson MD, Yu L-M, et al. J Am Coll Cardiol 2008 54 1787 94
42. Risk factor associations with the presence of a lipid core in carotid plaque of asymptomatic individuals using high-resolution MRI: the multi-ethnic study of atherosclerosis (MESA). Wasserman BA, Sharrett AR, Lai S, et al. Stroke 2008 39 329 35 10.1161/STROKEAHA.107.498634 18174475 (Pubitemid 351619451)
43. Identification of fibrous cap rupture with magnetic resonance imaging is highly associated with recent transient ischemic attack or stroke. Yuan C, Zhang Sx SX, Polissar NL, et al. Circulation 2002 105 181 5 10.1161/hc0202.102121 11790698 (Pubitemid 34084316)
44. Beneficial cardiovascular effects of bariatric surgical and dietary weight loss in obesity. Rider OJ, Francis JM, Ali MK, et al. J Am Coll Cardiol 2009 54 718 26 10.1016/j.jacc.2009.02.086 19679250
45. Relation of aortic wall thickness and distensibility to cardiovascular risk factors (from the Multi-Ethnic Study of Atherosclerosis [MESA]). Malayeri AA, Natori S, Bahrami H, et al. Am J Cardiol 2008 102 491 6 10.1016/j.amjcard. 2008.04.010 18678312
46. Reproducibility and accuracy of automated measurement for dynamic arterial lumen area by cardiovascular magnetic resonance. Jackson CE, Shirodaria CC, Lee JM, et al. Int J Cardiovasc Imaging 2009
47. Advanced Glycation End Products Accumulate in Vascular Smooth Muscle and Modify Vascular but Not Ventricular Properties in Elderly Hypertensive Canines. Shapiro BP, Owan TE, Mohammed SF, et al. Circulation 2008 118 1002 10 10.1161/CIRCULATIONAHA.108.777326 18711013
48. Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice. Lin R-Y, Choudhury RP, Cai W, et al. Atherosclerosis 2003 168 213 20 10.1016/S0021-9150(03)00050-9 12801603 (Pubitemid 36703319)
49. Cardiovascular magnetic resonance imaging for non-invasive assessment of vascular function: validation against ultrasound. Leeson CP, Robinson M, Francis JM, et al. J Cardiovasc Magn Reson 2006 8 381 7 10.1080/10976640500526993 16669182 (Pubitemid 43355112)